224 related articles for article (PubMed ID: 31580259)
1. Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation.
Yu X; Plotnikova O; Bonin PD; Subashi TA; McLellan TJ; Dumlao D; Che Y; Dong YY; Carpenter EP; West GM; Qiu X; Culp JS; Han S
Elife; 2019 Oct; 8():. PubMed ID: 31580259
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of the human neutral amino acid transporter ASCT2.
Garaeva AA; Oostergetel GT; Gati C; Guskov A; Paulino C; Slotboom DJ
Nat Struct Mol Biol; 2018 Jun; 25(6):515-521. PubMed ID: 29872227
[TBL] [Abstract][Full Text] [Related]
3. A one-gate elevator mechanism for the human neutral amino acid transporter ASCT2.
Garaeva AA; Guskov A; Slotboom DJ; Paulino C
Nat Commun; 2019 Jul; 10(1):3427. PubMed ID: 31366933
[TBL] [Abstract][Full Text] [Related]
4. Rational design of ASCT2 inhibitors using an integrated experimental-computational approach.
Garibsingh RA; Ndaru E; Garaeva AA; Shi Y; Zielewicz L; Zakrepine P; Bonomi M; Slotboom DJ; Paulino C; Grewer C; Schlessinger A
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507995
[TBL] [Abstract][Full Text] [Related]
5. Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism.
Scalise M; Pappacoda G; Mazza T; Console L; Pochini L; Indiveri C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163050
[TBL] [Abstract][Full Text] [Related]
6. Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport.
Scalise M; Pochini L; Console L; Pappacoda G; Pingitore P; Hedfalk K; Indiveri C
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495336
[TBL] [Abstract][Full Text] [Related]
7. Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds.
Ndaru E; Garibsingh RA; Shi Y; Wallace E; Zakrepine P; Wang J; Schlessinger A; Grewer C
J Gen Physiol; 2019 Mar; 151(3):357-368. PubMed ID: 30718375
[TBL] [Abstract][Full Text] [Related]
8. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
9. LncRNA
Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
[TBL] [Abstract][Full Text] [Related]
10. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
[TBL] [Abstract][Full Text] [Related]
11. Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5.
Scopelliti AJ; Font J; Vandenberg RJ; Boudker O; Ryan RM
Nat Commun; 2018 Jan; 9(1):38. PubMed ID: 29295993
[TBL] [Abstract][Full Text] [Related]
12. Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.
Yang Z; Follett J; Kerr MC; Clairfeuille T; Chandra M; Collins BM; Teasdale RD
J Biol Chem; 2018 May; 293(18):6802-6811. PubMed ID: 29563155
[TBL] [Abstract][Full Text] [Related]
13. Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening.
Colas C; Grewer C; Otte NJ; Gameiro A; Albers T; Singh K; Shere H; Bonomi M; Holst J; Schlessinger A
PLoS Comput Biol; 2015 Oct; 11(10):e1004477. PubMed ID: 26444490
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the neutral amino acid transporter ASCT2 with basic amino acids.
Ndaru E; Garibsingh RA; Zielewicz L; Schlessinger A; Grewer C
Biochem J; 2020 Apr; 477(8):1443-1457. PubMed ID: 32242892
[TBL] [Abstract][Full Text] [Related]
15. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.
Osman I; He X; Liu J; Dong K; Wen T; Zhang F; Yu L; Hu G; Xin H; Zhang W; Zhou J
Circ Res; 2019 Apr; 124(9):1309-1322. PubMed ID: 30801233
[TBL] [Abstract][Full Text] [Related]
16. Establishment of monoclonal antibodies against cell surface domains of ASCT2/SLC1A5 and their inhibition of glutamine-dependent tumor cell growth.
Suzuki M; Toki H; Furuya A; Ando H
Biochem Biophys Res Commun; 2017 Jan; 482(4):651-657. PubMed ID: 27865832
[TBL] [Abstract][Full Text] [Related]
17. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
[TBL] [Abstract][Full Text] [Related]
18. 2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency.
Schulte ML; Dawson ES; Saleh SA; Cuthbertson ML; Manning HC
Bioorg Med Chem Lett; 2015 Jan; 25(1):113-6. PubMed ID: 25435145
[TBL] [Abstract][Full Text] [Related]
19. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
[TBL] [Abstract][Full Text] [Related]
20. Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter.
Scalise M; Pochini L; Pingitore P; Hedfalk K; Indiveri C
FEBS Lett; 2015 Nov; 589(23):3617-23. PubMed ID: 26492990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
